April 2022 John Streicher talks about his work on terpenes found in cannabis as these may be a novel way to treat pain without the negative side effects "Many people are familiar with cannabis, but John

Join the #GPCR movement by becoming a site member for FREE!

Join us now ➡️ https://www.ecosystem.drgpcr.com/dr-gpcr-summit-2022 #gpcr #drgpcr

Authors and Affiliations John Stagg , David Allard . About John Stagg "John Stagg is a Professor of Pharmacy at Université de Montréal and researcher at the Distinguished immunologist, Dr Stagg is recognized for having identified the adenosine-producing enzyme Dr Stagg has served as an expert consultant in the development of adenosine-targeting drugs, several John Stagg on the web University of Montréal Québec Cancer Consortium The University of Montreal Hospital

Welcome Remarks Read More Thursday, November 2nd / 1:45 PM - 2:45 PM Trainee Symposium I Eric Johansen , Johns University Read More Friday, November 3rd / 4:35 PM Targeting adenosine signaling for immuno-oncology John Stagg CHUM, Université de Montréal Read More Friday, November 3rd / 5:00 PM Poster Session #2 Read More

John Streicher About this episode Our guest in this episode of the Dr.GPCR podcast is Dr. John Streicher from the department of pharmacology at the University of Arizona. John started grad school in 1999 and spent some time figuring out what he was interested in. Today, John and his team focus on understanding how signal transduction cascades downstream of the opioid John Streicher on the web University of Arizona Department of Pharmacology Google Scholar Pubmed LinkedIn